Pharmaceuticals

"Pharmaceuticals" Main

Latest Morning Briefing Stories

EU Deal Allows AstraZeneca Partial Immunity Over Vaccine Side-Effects

KHN Morning Briefing

The deal was struck in August and its liability clauses have not previously been reported, according to Reuters and CNBC. Other vaccine news is on the trials being run by Novavax and Sanofi, and more. And also: New York’s decision to review vaccines.

Medicare Recipients Will Get $200 Card For Prescriptions, Trump Says

KHN Morning Briefing

He tucked the news into a speech about his health care vision but didn’t provide many details. It’s possible the cards may be intended to help seniors pay for the COVID vaccine, which reportedly might not be covered by Medicare.

Kids Will Likely Be At The Back Of The Vaccine Line

KHN Morning Briefing

With no clinical trials underway, a COVID-19 vaccine for children is unlikely before the fall of 2021. Other news stories report the latest on vaccine development by Sanofi, Merck and AstraZeneca.

Trump Threatens To Nix FDA Proposal For Stricter Vaccine Standards

KHN Morning Briefing

“That has to be approved by the White House. We may or may not approve it. That sounds like a political move,” President Donald Trump said about a draft FDA plan to apply tougher safety and efficacy requirements for emergency use approval of a COVID-19 vaccine.

FDA Proposes Harder-To-Clear Guidelines For Emergency Vaccine Approval

KHN Morning Briefing

Draft guidelines submitted by the FDA to the White House propose standards for authorizing emergency use of a COVID-19 vaccine that match ones set for regular vaccine approval, The Washington Post reported. The agency’s move aims to reassure the public about vaccine safety and lowers the chances that one might be cleared before the Nov. 3 election.

State Treasurers Want Gilead To Slash Price Of Remdesivir

KHN Morning Briefing

In a letter Wednesday, 11 state officials asked the company to “responsibly commit to being a part of our nation’s recovery from COVID-19, both medically and economically, by repricing this drug more affordably.”

Anti-Mask Republican Congressman Will Lead COVID Drug Trial

KHN Morning Briefing

Rep. Andy Harris (R-Md.) is on the data and safety monitoring committee for the drug aviptadil. The five-term congressman’s membership on the board is unusual; former FDA chief Scott Gottlieb told Politico he hadn’t heard of a member of Congress sitting on such a committee for any drug. Surgeon General Jerome Adams and Dr. Anthony Fauci also make headlines.

Moderna, Pfizer Reveal Vaccine Designs

KHN Morning Briefing

Companies typically share these plans after studies are complete, but both companies hope to earn the trust of the public and scientists.

Farmers To Receive Additional $13B In Coronavirus Relief, Trump Says

KHN Morning Briefing

President Donald Trump announced the second round of aid for farmers during a reelection rally in Wisconsin. More details are expected today. Other Trump campaign news covers drug importation and pricing, the United Nations and opioids.